Literature DB >> 21476030

The protective effect of the recombinant 53-kDa protein of Trichinella spiralis on experimental colitis in mice.

Linlin Du1, Hao Tang, Zhongfu Ma, Jia Xu, Wenchao Gao, Jiajia Chen, Wenjia Gan, Zhaoping Zhang, Xinbing Yu, Xingwang Zhou, Xuchu Hu.   

Abstract

BACKGROUND: Helminth infection has been proven to reduce the severity of experimental inflammatory bowel disease (IBD). The excretory-secretory proteins of helminths play an important role in the process of immunomodulation. AIMS: In the present study, we aimed to investigate the protective potential of recombinant Trichinella spiralis (TS) 53-kDa protein (rTsP53), a component of excretory-secretory proteins, on experimental colitis in mice.
METHODS: BALB/c mice were treated subcutaneously with 50 μg rTsP53 three times at an interval of 5 days. Colitis was induced by intrarectal administration of 5 mg trinitrobenzene sulfonic acid (TNBS). Disease activities and macroscopic and microscopic scores were evaluated. To determine immune response provoked by rTsP53, we measured specific IgG1 and IgG2a values against rTsP53 in sera of mice. We also detected cytokine profiles as well as the markers of alternatively activated macrophages (M2) in mice.
RESULTS: RTsP53 ameliorated significantly the disease activity index (DAI) as well as the macroscopic and microscopic scores. IgG1 but not IgG2a was the predominant specific antibody detected in the sera of immunized mice, indicating the potential of stimulating T-helper (Th) 2 bias response by rTsP3. Pre-treatment with rTsP53 decreased serum Th1 cytokines (TNF-a, IFN-γ) and elevated serum levels of serum Th2 cytokines (IL-4, IL-13); it also decreased colonic Th1 cytokines (TNF-α, IL-6) and colonic regulatory cytokines (IL-10, TGF-β1). RTsP53 increased colonic M2 markers, arginase-1 (Arg-1), and found in inflammatory zone 1 (FIZZ1), compared to mice without rTsP53 pretreatment.
CONCLUSIONS: RTsP53 is a potential protective agent for IBD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21476030     DOI: 10.1007/s10620-011-1689-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

Review 1.  Transcriptional regulation of Th1/Th2 polarization.

Authors:  J Rengarajan; S J Szabo; L H Glimcher
Journal:  Immunol Today       Date:  2000-10

Review 2.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

3.  Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites.

Authors:  Robert M Anthony; Joseph F Urban; Farhang Alem; Hossein A Hamed; Cristina T Rozo; Jean-Luc Boucher; Nico Van Rooijen; William C Gause
Journal:  Nat Med       Date:  2006-07-30       Impact factor: 53.440

4.  Effects of tumour necrosis factor-alpha synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis.

Authors:  C Bobin-Dubigeon; X Collin; N Grimaud; J M Robert; G Le Baut; J Y Petit
Journal:  Eur J Pharmacol       Date:  2001-11-09       Impact factor: 4.432

5.  Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy.

Authors:  J G Fox; P Beck; C A Dangler; M T Whary; T C Wang; H N Shi; C Nagler-Anderson
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

6.  Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis.

Authors:  Meaghan M Hunter; Arthur Wang; Christina L Hirota; Derek M McKay
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

7.  Does the failure to acquire helminthic parasites predispose to Crohn's disease?

Authors:  D E Elliott; J R Urban JF; C K Argo; J V Weinstock
Journal:  FASEB J       Date:  2000-09       Impact factor: 5.191

8.  Development and evaluation of a Western blot kit for diagnosis of human trichinellosis.

Authors:  Hélène Yera; Shakir Andiva; Catherine Perret; Denis Limonne; Pascal Boireau; Jean Dupouy-Camet
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

9.  Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice.

Authors:  Nathalie E Ruyssers; Benedicte Y De Winter; Joris G De Man; Alex Loukas; Mark S Pearson; Joel V Weinstock; Rita M Van den Bossche; Wim Martinet; Paul A Pelckmans; Tom G Moreels
Journal:  Inflamm Bowel Dis       Date:  2009-04       Impact factor: 5.325

10.  Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism.

Authors:  Philip Smith; Niamh E Mangan; Caitriona M Walsh; Rosie E Fallon; Andrew N J McKenzie; Nico van Rooijen; Padraic G Fallon
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

View more
  32 in total

Review 1.  Therapeutic potential of helminths in autoimmune diseases: helminth-derived immune-regulators and immune balance.

Authors:  Meng Wang; Linxiang Wu; Rennan Weng; Weihong Zheng; Zhongdao Wu; Zhiyue Lv
Journal:  Parasitol Res       Date:  2017-06-29       Impact factor: 2.289

2.  Nonencapsulated Trichinella pseudospiralis Infection Impairs Follicular Helper T Cell Differentiation with Subclass-Selective Decreases in Antibody Responses.

Authors:  Kazunobu Asano; Zhiliang Wu; Piyarat Srinontong; Takahide Ikeda; Isao Nagano; Hirokuyi Morita; Yoichi Maekawa
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

3.  Amelioration of type 1 diabetes by recombinant fructose-1,6-bisphosphate aldolase and cystatin derived from Schistosoma japonicum in a murine model.

Authors:  Ke Yan; Bo Wang; Huabang Zhou; Qingli Luo; Jilong Shen; Yunxia Xu; Zhengrong Zhong
Journal:  Parasitol Res       Date:  2019-12-16       Impact factor: 2.289

4.  Exposure time determines the protective effect of Trichinella spiralis on experimental colitis.

Authors:  Wenxiao Zheng; Zhenrong Ma; Xi Sun; Yehong Huang; Bin Lu; Xiaogang Chen; Xiang Xue; Xuexian Yang; Xiang Wu
Journal:  Microb Pathog       Date:  2020-05-20       Impact factor: 3.738

5.  Hookworm excretory/secretory products induce interleukin-4 (IL-4)+ IL-10+ CD4+ T cell responses and suppress pathology in a mouse model of colitis.

Authors:  Ivana Ferreira; Danielle Smyth; Soraya Gaze; Ammar Aziz; Paul Giacomin; Nathalie Ruyssers; David Artis; Thewarach Laha; Severine Navarro; Alex Loukas; Henry J McSorley
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

6.  Analysis of a novel cathepsin B circulating antigen and its response to drug treatment in Trichinella-infected mice.

Authors:  Jian-hua Zhan; Jian-ping Yao; Wei Liu; Xu-chu Hu; Zhong-dao Wu; Xing-wang Zhou
Journal:  Parasitol Res       Date:  2013-07-05       Impact factor: 2.289

Review 7.  Helminth infections and host immune regulation.

Authors:  Henry J McSorley; Rick M Maizels
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  SXP-RAL Family Filarial Protein, rWbL2, Prevents Development of DSS-Induced Acute Ulcerative Colitis.

Authors:  Namdev S Togre; Priyanka S Bhoj; Vishal K Khatri; Aditya Tarnekar; Kalyan Goswami; Moreshwar R Shende; M V R Reddy
Journal:  Indian J Clin Biochem       Date:  2017-09-15

9.  Treatment with Cestode Parasite Antigens Results in Recruitment of CCR2+ Myeloid Cells, the Adoptive Transfer of Which Ameliorates Colitis.

Authors:  José L Reyes; Fernando Lopes; Gabriella Leung; Nicole L Mancini; Chelsea E Matisz; Arthur Wang; Emma A Thomson; Nicholas Graves; John Gilleard; Derek M McKay
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

Review 10.  Translatability of helminth therapy in inflammatory bowel diseases.

Authors:  Joel V Weinstock; David E Elliott
Journal:  Int J Parasitol       Date:  2012-11-21       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.